Growth Metrics

CorMedix (CRMD) Income towards Parent Company (2016 - 2025)

CorMedix (CRMD) has disclosed Income towards Parent Company for 14 consecutive years, with $14.0 million as the latest value for Q4 2025.

  • Quarterly Income towards Parent Company fell 56.9% to $14.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $163.1 million through Dec 2025, up 14253.43% year-over-year, with the annual reading at $163.1 million for FY2025, 14253.43% up from the prior year.
  • Income towards Parent Company hit $14.0 million in Q4 2025 for CorMedix, down from $108.6 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $108.6 million in Q3 2025 to a low of -$14.5 million in Q1 2024.
  • Historically, Income towards Parent Company has averaged $3.8 million across 5 years, with a median of -$7.2 million in 2021.
  • Biggest five-year swings in Income towards Parent Company: tumbled 64.15% in 2022 and later soared 4009.63% in 2025.
  • Year by year, Income towards Parent Company stood at -$9.7 million in 2021, then grew by 15.08% to -$8.2 million in 2022, then decreased by 18.7% to -$9.7 million in 2023, then skyrocketed by 433.84% to $32.5 million in 2024, then crashed by 56.9% to $14.0 million in 2025.
  • Business Quant data shows Income towards Parent Company for CRMD at $14.0 million in Q4 2025, $108.6 million in Q3 2025, and $19.8 million in Q2 2025.